(firstQuint)MP Diagnostics HTLV Blot 2.

4 Post-Market Clinical Study.

 The HTLV Blot 2.

4 Post-Market Clinical Study is an open-label, multi-center, single-blind clinical study of neurological disorders (n=100) and HTLV known-positive (KP) specimens (n=50).

 This study is being conducted to support additional labeling claims and to further assess the sensitivity and specificity of the HTLV Blot 2.

4 in specimens with neurological disorders and HTLV known positive specimens.

.

 MP Diagnostics HTLV Blot 2.

4 Post-Market Clinical Study@highlight

This post-market study is intended to assess the performance of the HTLV Blot 2.

4 in repository serum/plasma specimens with neurological disorders (n=100) or an HTLV known positive infection (n=50).

